High incidence of skin reactions secondary to the use of adhesives in glucose sensors or insulin pumps for the treatment of children with type 1 diabetes
Authors' conclusion
This study confirms the high incidence of skin reactions to adhesive devices used in the treatment of type 1 diabetes in children.
Study context
- Population
- Children with T1D using continuous subcutaneous insulin infusion (CSII) or continuous glucose monitoring (CGM); 46% girls, mean age 11.75 years
- Participants
- 198 children
- Exposure
- Children with vs without skin reactions
- Skin reactionsn = 67
- Outcome
- Incidence of skin reactions secondary to CSII or CGM sensors
Methodological detailssingle-centre, standardised questionnaire, univariate and multivariate analysis
- Single-centre
- Standardised questionnaire
- Univariate and multivariate analysis
Main finding
As reported in the abstract
Active skin reactions
Active skin reactions, all children
67
33.8%
Active skin reactions with CSII
45
30.4%
Active skin reactions with CGM
46
23.5%
Observational data: associations, not effects.
Further findings
Age · younger with skin reactions
P < 0.05
Age at diabetes diagnosis · younger at diagnosis with skin reactions
P < 0.05
Atopy
P < 0.05
Personal history of atopy associated with skin reactions (multivariate analysis)
- OR for skin reactions with personal history of atopy, 1.16-5.97 interval as printed, p < 0.05
- 2.56
- Only factor associated on multivariate analysis
Original publication
High incidence of skin reactions secondary to the use of adhesives in glucose sensors or insulin pumps for the treatment of children with type 1 diabetes. Diabetes Res Clin Pract. Published 26 September 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →